<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Bendelic, E.C.</creatorName>
</creator>
<creator>
<creatorName>Boişteanu, V.E.</creatorName>
</creator>
<creator>
<creatorName>Jeru, I.N.</creatorName>
</creator>
</creators>
<titles>
<title xml:lang='ro'>BIO-rul în perioada postoperatorie după extracţia extracapsulară a cataractei senile cu implantare de lentile intraoculare</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2008</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1857-1719</relatedIdentifier>
<dates>
<date dateType='Issued'>2008-10-15</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='ro' descriptionType='Abstract'>În studiu au fost incluşi 64 pacienţi cu vârsta de 55-75 ani după extracţia extracapsulară a cataractei senile cu lentile intraoculare. La 32 pacienţi în postoperator s-a administrat Sol. Dexametazonă – 1,0 ml subconjunctival. La 32 pacienţi în perioada dată s-a administrat Sol. BIO-R – 0,5 ml subconjunctival. Procese degenerative mai diminuate ale conjnctivei şi corneei s-au determinat la administrarea BIO-Rului.</description>
<description xml:lang='en' descriptionType='Abstract'>64 patients (aged 55-75 years) have been investigated after extracapsular senile cataract extraction with implantation of intraocular lenses. Sol. Dexamethason (1,0 ml subconjunctivally) 
has been administrated in 32 patients, and BIO-R (0,5 ml subconjunctivally) in other 32 patients. Degenerative modifications of conjunctiva and cornea were less expressed in patients who 
recieved BIO-R.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>